J.Safra Asset Management Corp

Position in JNJ — Johnson & Johnson

CIK 1535293 NEW YORK, NY

Position in JNJ

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$1,062,102

+$60,632 QoQ

Shares Held

4,182

+2.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.12%

of 13F equity value

Holder Rank

#2,964

of 4,664 holders

Holding Since

Mar 2022

17 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

J.Safra Asset Management Corp holds $13,218,561 across 10 Drug Manufacturers - General names. JNJ ranks #4 (8.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	6,918	$8,297,657
2	ABBV	AbbVie Inc.	5,519	$1,388,801
3	AMGN	Amgen Inc	3,204	$1,160,232
4	JNJ	Johnson & Johnson This page	4,182	$1,062,102
5	AZN	Astrazeneca PLC	3,599	$682,442
6	MRK	Merck & Co., Inc.	4,298	$552,293
7	GILD	Gilead Sciences, Inc.	275	$34,743
8	NVO	Novo Nordisk A S	428	$20,518

17 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,062,102	4,182	+2.1%	Shares	Sole	2026-08-06
2026-03-31	$1,001,470	4,097	+7.9%	Shares	Sole	2026-05-04
2025-12-31	$785,789	3,797	+426.6%	Shares	Sole	2026-02-11
2025-09-30	$133,687	721	0.0%	Shares	Sole	2025-10-29
2025-06-30	$110,132	721	0.0%	Shares	Sole	2025-10-29
2025-03-31	$119,570	721	0.0%	Shares	Sole	2025-10-29
2024-12-31	$104,271	721	0.0%	Shares	Sole	2025-02-06
2024-09-30	$116,845	721	0.0%	Shares	Sole	2024-11-13
2024-06-30	$105,381	721	-31.1%	Shares	Sole	2024-07-17
2024-03-31	$165,624	1,047	+37.6%	Shares	Sole	2024-05-09
2023-12-31	$119,279	761	+5.5%	Shares	Sole	2024-02-02
2023-09-30	$112,295	721	0.0%	Shares	Sole	2023-11-13
2023-06-30	$119,339	721	0.0%	Shares	Sole	2023-08-04
2023-03-31	$111,755	721	+516.2%	Shares	Sole	2023-05-12
2022-09-30	$19,113	117	-7.9%	Shares	Sole	2022-11-07
2022-06-30	$22,543	127	0.0%	Shares	Sole	2022-08-01
2022-03-31	$22,508	127	—	Shares	Sole	2022-05-09
No filing history on record for this holder in this stock.